接纳承诺疗法治疗精神病性障碍:随机对照试验
该随机对照试验将96例社区居住的持续性精神病性症状患者分配至接纳承诺疗法(ACT)组(n=49)或友好访问组(n=47),主要结局为治疗后总体精神状态(PANSS总分)。结果显示两组总体精神状态无组间差异,但ACT组在随访时阳性症状和幻觉痛苦方面改善更明显。
要点
- ACT组与友好访问组在治疗后PANSS总分上无显著组间差异。
- 随访时ACT组阳性症状改善优于对照组,效应量Cohen's d=0.52(95%CI 0.07-0.98)。
- 随访时ACT组幻觉痛苦改善优于对照组,效应量Cohen's d=0.65(95%CI 0.24-1.06)。
核心结论
- ACT在总体精神状态上未显示优于友好访问的疗效,但在阳性症状和幻觉痛苦方面表现出随访期改善。
- 过程测量未见变化,提示所用ACT干预并未超越友好访问而操纵目标过程。
研究设计与样本
- 随机对照试验,纳入96例社区居住的持续性精神病性症状患者,随机分为ACT组(n=49)和友好访问组(n=47)。
- 主要结局为治疗后总体精神状态(阳性和阴性综合征量表PANSS总分),次要结局为精神病性症状维度和功能。
主要发现
- 主要结局PANSS总分无组间差异。
- 随访时ACT组阳性症状改善优于对照组,Cohen's d=0.52(95%CI 0.07-0.98)。
- 随访时ACT组幻觉痛苦改善优于对照组,Cohen's d=0.65(95%CI 0.24-1.06)。
- 过程测量未见变化。
临床怎么用
- ACT可能对持续性精神病性症状患者的阳性症状和幻觉痛苦有随访期益处,但总体精神状态未见优势。
- 未来需针对症状特异性治疗优化、过程测量改进以及认知功能和治疗剂量予以关注。
局限性
- 过程测量无变化提示ACT干预未超越友好访问而操纵目标过程。
- 作者指出需未来研究进行症状特异性治疗优化、改进过程探究并关注认知功能与剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The efficacy of acceptance and commitment therapy (ACT) in psychosis has been reported but not for medication-resistant psychosis. AIMS: To test the efficacy of ACT in a sample of community-residing patients with persisting psychotic symptoms. (Australian New Zealand Clinical Trials Registry: ACTRN12608000210370.) METHOD: The primary outcome was overall mental state at post-therapy (Positive and Negative Syndrome Scale - total); secondary outcomes were psychotic symptom dimensions and functioning. In total, 96 patients were randomised to ACT (n = 49) or befriending (n = 47). Symptom, functioning and process measures were administered at baseline, post-therapy and 6 months later. RESULTS: There was no group difference on overall mental state. In secondary analyses the ACT group showed greater improvement in positive symptoms and hallucination distress at follow-up: Cohen's d = 0.52 (95% CI 0.07-0.98) and 0.65 (95% CI 0.24-1.06), respectively. CONCLUSIONS: Improvements reflected the treatment focus on positive symptoms; however, absence of process-measure changes suggests that the ACT intervention used did not manipulate targeted processes beyond befriending. Symptom-specific therapy refinements, improved investigation of process and attention to cognitive functioning and dose are warranted in future research.
引用
- Shawyer F, Farhall J, Thomas N, et al. Acceptance and commitment therapy for psychosis: randomised controlled trial. Br J Psychiatry. 2016. PMID: 27979820. doi:10.1192/bjp.bp.116.182865
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。